PURPOSE: To develop safe and effective manganese(II) -based biodegradable macromolecular MRI contrast agents. MATERIALS AND METHODS: In this study, we synthesized and characterized two polydisulfide manganese(II) complexes, Mn-DTPA cystamine copolymers and Mn-EDTA cystamine copolymers, as new biodegradable macromolecular MRI contrast agents. The contrast enhancement of the two manganese-based contrast agents were evaluated in mice bearing MDA-MB-231 human breast carcinoma xenografts, in comparison with MnCl(2) . RESULTS: The T(1) and T(2) relaxivities were 4.74 and 10.38 mM(-1) s(-1) per manganese at 3T for Mn-DTPA cystamine copolymers (M(n) = 30.50 kDa) and 6.41 and 9.72 mM(-1) s(-1) for Mn-EDTA cystamine copolymers (M(n) = 61.80 kDa). Both polydisulfide Mn(II) complexes showed significant liver, myocardium and tumor enhancement. CONCLUSION: The manganese-based polydisulfide contrast agents have a potential to be developed as alternative non-gadolinium contrast agents for MR cancer and myocardium imaging.
PURPOSE: To develop safe and effective manganese(II) -based biodegradable macromolecular MRI contrast agents. MATERIALS AND METHODS: In this study, we synthesized and characterized two polydisulfidemanganese(II) complexes, Mn-DTPA cystamine copolymers and Mn-EDTA cystamine copolymers, as new biodegradable macromolecular MRI contrast agents. The contrast enhancement of the two manganese-based contrast agents were evaluated in mice bearing MDA-MB-231humanbreast carcinoma xenografts, in comparison with MnCl(2) . RESULTS: The T(1) and T(2) relaxivities were 4.74 and 10.38 mM(-1) s(-1) per manganese at 3T for Mn-DTPA cystamine copolymers (M(n) = 30.50 kDa) and 6.41 and 9.72 mM(-1) s(-1) for Mn-EDTA cystamine copolymers (M(n) = 61.80 kDa). Both polydisulfideMn(II) complexes showed significant liver, myocardium and tumor enhancement. CONCLUSION: The manganese-based polydisulfide contrast agents have a potential to be developed as alternative non-gadolinium contrast agents for MR cancer and myocardium imaging.
Authors: Dipanjan Pan; Shelton D Caruthers; Angana Senpan; Ann H Schmieder; Samuel A Wickline; Gregory M Lanza Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2010-09-21
Authors: Jeffrey S Troughton; Matthew T Greenfield; Jaclyn M Greenwood; Stéphane Dumas; Andrea J Wiethoff; Jufeng Wang; Marga Spiller; Thomas J McMurry; Peter Caravan Journal: Inorg Chem Date: 2004-10-04 Impact factor: 5.165
Authors: Andreas Kribben; Oliver Witzke; Uwe Hillen; Jörg Barkhausen; Anton E Daul; Raimund Erbel Journal: J Am Coll Cardiol Date: 2009-05-05 Impact factor: 24.094
Authors: Zheng-Rong Lu; Dennis L Parker; K Craig Goodrich; Xinghe Wang; John G Dalle; Henry R Buswell Journal: Magn Reson Med Date: 2004-01 Impact factor: 4.668